Wegovy and Ozempic are two different medications that belong to the same class of drugs called GLP-1 agonists, which are used to treat type 2 diabetes and obesity. Wegovy is a relatively new medication that was approved by the FDA in June 2021 [1], while Ozempic has been on the market since December 2017 [3].

According to GoodRx, the cost of Wegovy is around $1,317 for a 4-week supply of the 2.4mg dose, which is the only available dose of Wegovy [2]. On the other hand, the cost of Ozempic ranges from $856 to $1,083 for a 4-week supply of the 0.5mg or 1mg dose, respectively [2].

However, it is important to note that the actual cost of these medications may vary depending on several factors such as insurance coverage, pharmacy location, and discounts. For instance, Drug Patent Watch states that Wegovy's price may be reduced by up to 80% with the use of a discount card [1]. Similarly, GoodRx reports that the price of Ozempic can be reduced by up to 20% with the use of a coupon [2].

In conclusion, the cost of Wegovy appears to be higher than that of Ozempic, but the actual cost may vary depending on various factors. Patients are advised to consult with their healthcare provider and pharmacist to determine the most cost-effective option for their individual needs.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.goodrx.com/classes/glp-1-agonists/wegovy-vs-ozempic
[3] https://quick.md/blog/drugs-information-prices/ozempic-versus-wegovy/